Provides for education and outreach for drug-induced movement disorders by the department of health through the health care and wellness education and outreach program.
Summary
A01017 amends the Public Health Law to expand the state’s drug-induced movement disorder education and outreach program. The bill directs the Department of Health, through the health care and wellness education and outreach program, to develop and disseminate information about drug-induced movement disorders, with emphasis on screening, identifying symptoms, and treatment. It also adds language about reducing or eliminating stigma experienced by people living with these disorders, particularly in connection with treatment for mental health conditions.
The bill further requires educational materials for health care providers to be developed in consultation with the commissioner of the Office of Mental Health and disseminated by the department in coordination with relevant provider groups. Those materials must include best practices for screening and treatment informed by the American Psychiatric Association and other professional society guidelines. The act is tied to a prior 2024 law establishing the underlying screening education program and would take effect when that earlier law takes effect.
In practical terms, the bill updates state public health policy by clarifying and broadening the Department of Health’s authority and responsibilities around education on drug-induced movement disorders. It affects the department, health care providers, and organizations involved in mental health and neurological care, but it does not create a new benefit or mandate for patients directly. Instead, it focuses on provider education, public outreach, and stigma reduction within the existing health education framework.
The overall sentiment around the bill appears strongly favorable and noncontroversial. It passed the Assembly Health Committee unanimously, then passed the Assembly floor 147-0 and the Senate floor 61-0, indicating broad bipartisan support. The lack of recorded opposition suggests the bill was viewed as a technical or supportive public health measure rather than a contentious policy change.
There is little visible contention in the available record. The main policy emphasis is on how the education program should be implemented—particularly the role of the Office of Mental Health, coordination with provider groups, and the inclusion of professional guidelines and stigma-reduction messaging. Any debate would likely center on program design and scope, but the unanimous votes indicate no significant disagreement in the legislative process.
Impact
The bill amends section 207 of the Public Health Law to expand and clarify the Department of Health’s authority to educate the public and health care providers about drug-induced movement disorders. It requires dissemination of screening, symptom-identification, treatment, and stigma-reduction information, and it directs provider-facing materials to be developed with the Office of Mental Health and coordinated with relevant professional groups. The measure builds on and takes effect with the 2024 law establishing the underlying screening education program, affecting state public health administration, mental health coordination, and provider education practices.
Sentiment
The bill received overwhelmingly positive treatment in the legislative process. It was approved unanimously in the Assembly Health Committee and then passed both chambers with no recorded opposition, suggesting broad agreement that the measure is a useful public health and provider-education update. The votes indicate the bill was viewed as a low-conflict, supportive extension of an existing program rather than a controversial policy shift.
Contention
No major contention is evident in the available materials. The only potentially debatable issues are implementation details: the extent of the Department of Health’s outreach duties, the requirement to consult with the Office of Mental Health, and the use of professional society guidelines in educational materials. However, the unanimous committee and floor votes suggest these points did not generate meaningful opposition among lawmakers.
Same As
Provides for education and outreach for drug-induced movement disorders by the department of health through the health care and wellness education and outreach program.
Provides for education and outreach for drug-induced movement disorders by the department of health through the health care and wellness education and outreach program.
Requires the health care and wellness education and outreach program of the department of health to provide information regarding pressure ulcers for consumers, patients, educators and health care providers.
Includes information on congenital heart defect births as part of the department of health's health care and wellness education and outreach program; amends the effectiveness thereof.